Replies to post #24595 on Intellipharmaceutics International Inc. (IPCI)

[Amigo Mike]

Angelo,

Quote:Par provides reports, probably monthly - your assumption
That's an assumption on your part... you cannot deduce that from the terminology in the contract.

That is correct. I cannot deduce the timing of Par's reporting based on the terminology in the contract.

One need only ask Della Penna .......

IN fact .... even mentioned in the most recent presentation ..... #1 "catalyst" (LOL). Anticipate higher revenues for Q1 2017 due to 25/35mg Focalin launch.

So IMO, IPCI will be reporting estimated licensing revenues they can reasonably expect to receive as earned for the new focalin doses for the F1Q report even though they will not have received the money.

Amigo Mike